These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 73809)

  • 21. Phenylalanine hydroxylase deficiency in the peripheral lymphocytes from phenylketonuria.
    Yoshii T; Toda K; Kobori T
    J Dermatol; 1977 Apr; 4(2):49-52. PubMed ID: 15461325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vivo studies of phenylalanine metabolism].
    Hjalmarsson O; Jagenburg R; Rödjer S
    Lakartidningen; 1974 Mar; 71(12):1171-2. PubMed ID: 4821502
    [No Abstract]   [Full Text] [Related]  

  • 23. [Genetical heterogeneity of phenylketonuria].
    Annenkov GA
    Vopr Med Khim; 1982; 28(3):62-70. PubMed ID: 7048735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of atypical phenylketonuria.
    Pollitt RJ
    Lancet; 1979 Mar; 1(8116):618. PubMed ID: 85217
    [No Abstract]   [Full Text] [Related]  

  • 25. Kinetics of phenylalanine disappearance after intravenous load in phenylketonuria and its genetic variants.
    Rey F; Blandin-Savoja F; Rey J
    Pediatr Res; 1979 Jan; 13(1):21-5. PubMed ID: 431997
    [No Abstract]   [Full Text] [Related]  

  • 26. Minimally invasive (13)C-breath test to examine phenylalanine metabolism in children with phenylketonuria.
    Turki A; Murthy G; Ueda K; Cheng B; Giezen A; Stockler-Ipsiroglu S; Elango R
    Mol Genet Metab; 2015; 115(2-3):78-83. PubMed ID: 25943030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene Editing Successfully Corrects 2 Amino Acid Disorders: In 2 preclinical studies using CRISPR-mediated gene editing, phenylketonuria and hereditary tyrosinemia type 1 were corrected.
    Am J Med Genet A; 2019 Jan; 179(1):5-6. PubMed ID: 30681273
    [No Abstract]   [Full Text] [Related]  

  • 28. Recovery of neurogenic amines in phenylketonuria mice after liver-targeted gene therapy.
    Yagi H; Sanechika S; Ichinose H; Sumi-Ichinose C; Mizukami H; Urabe M; Ozawa K; Kume A
    Neuroreport; 2012 Jan; 23(1):30-4. PubMed ID: 22107842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sapropterin dihydrochloride: a new drug and a new concept in the management of phenylketonuria.
    Trefz FK; Belanger-Quintana A
    Drugs Today (Barc); 2010 Aug; 46(8):589-600. PubMed ID: 20830319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new variant form of phenylketonuria.
    Watts RW; Purkiss P; Chalmers RA
    Q J Med; 1979 Jul; 48(191):403-17. PubMed ID: 317358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenylketonuria and other phenylalanine hydroxylation mutants in man.
    Scriver CR; Clow CL
    Annu Rev Genet; 1980; 14():179-202. PubMed ID: 7011173
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies of phenylketonurics with dermatitis.
    Fisch RO; Tsai MY; Gentry WC
    J Am Acad Dermatol; 1981 Mar; 4(3):284-90. PubMed ID: 7217397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low therapeutic threshold for hepatocyte replacement in murine phenylketonuria.
    Hamman K; Clark H; Montini E; Al-Dhalimy M; Grompe M; Finegold M; Harding CO
    Mol Ther; 2005 Aug; 12(2):337-44. PubMed ID: 16043102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hyperphenylalaninemia on account of biopterin deficiency. The phenylalanine hydroxylase complex and presentation of a patient with cofactor deficiency].
    Beck B
    Ugeskr Laeger; 1983 Nov; 145(48):3725-7. PubMed ID: 6665886
    [No Abstract]   [Full Text] [Related]  

  • 35. The NIH-shift in the in vivo hydroxylation of ring-deuterated L-phenylalanine in man.
    Lehmann WD; Heinrich HC
    Arch Biochem Biophys; 1986 Oct; 250(1):180-5. PubMed ID: 3767371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenylketonuria: Direct and indirect effects of phenylalanine.
    Schlegel G; Scholz R; Ullrich K; Santer R; Rune GM
    Exp Neurol; 2016 Jul; 281():28-36. PubMed ID: 27091224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenylalanine hydroxylation in isolated rat kidney tubules.
    Askin D; Green AK; Dickson AJ; Fisher MJ
    Int J Biochem; 1990; 22(1):107-14. PubMed ID: 2328817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rescuing proteins of low kinetic stability by chaperones and natural ligands phenylketonuria, a case study.
    Martinez A; Calvo AC; Teigen K; Pey AL
    Prog Mol Biol Transl Sci; 2008; 83():89-134. PubMed ID: 19186253
    [No Abstract]   [Full Text] [Related]  

  • 39. In vivo determination of phenylalanine hydroxylase activity using heptadeutero-phenylalanine and comparison to the in vitro assay values.
    Trefz FK; Bartholomé K; Bickel H; Lutz P; Schmidt H
    Monogr Hum Genet; 1978; 9():108-13. PubMed ID: 732825
    [No Abstract]   [Full Text] [Related]  

  • 40. Phenylketonuria: epitome of human biochemical genetics (second of two parts).
    Scriver CR; Clow CL
    N Engl J Med; 1980 Dec; 303(24):1394-400. PubMed ID: 7432385
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.